Sterility Testing Market Research Report - Global Forecast till 2023

Sterility Testing Market Research Report - Global Forecast till 2023

ID: MRFR/HC/0104-CRR | June, 2018 | Region: Global | 115 pages | Cooked Research Reports

Global Sterility Testing Market Research Report:  Product Type (Instruments, Services), Test Type (Membrane Filtration, Direct Transfer) End-User (Pharmaceutical Companies, Hospitals & Clinics, Academic & Research Laboratories) – Global Forecast Till 2023


The global sterility testing market is anticipated to reach USD 1,245.2 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit an 11.7% CAGR during the assessment period (2017-2023). High prevalence of cardiovascular diseases and various cancers are expected to induce market demand. Government support in terms of funding coupled with the expanding life science sector is anticipated to bode well for the market during the forecast period.


Sterility testing is essential for research and development purposes in pharmaceutical companies. It is a crucial step for determining the safety of drugs before consumption. In addition, sterility testing is also conducted in specific rooms in facilities to keep it germ-resistant. Drugs and vaccines undergone sterility testing can be commoditized and made commercially available to the masses. This can be beneficial to patients afflicted with cancer and cardiovascular diseases.


Report Overview


This report allows the user to gain a deeper understanding of the ongoing events and trends in the global market for sterility testing. By correlating the historical data with key market dynamics, analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global sterility testing market segmented by product type, test type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.


Segment Overview


By product type, the sterility testing market has been segmented into instruments, consumables, and services. The services segment is further segmented into sterility assurance tests, sterility validations, cleaning and disinfection, and stability testing. By test type, the market is segmented into product flush sterility testing, membrane filtration sterility testing, direct transfer sterility testing, and others. By end-user, the market is segmented into academic and research laboratories, pharmaceutical companies, hospitals and clinics, and others.  


The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “sterility testing” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.


Players Covered


Bioquell U.K. Ltd., Belimed Deutschland GmbH, Baxter BioPharma Solutions, Charles River Laboratories Inc., Boston Scientific Corporation, BioMérieux SA, Thermo Fisher Scientific Inc., SGS SA, Pacific BioLabs Inc., WuXi AppTec, Astell Scientific, Sartorius AG, Becton, Dickinson and Company, Merck KGaA, and others are prominent players in the sterility testing market.


The report offers comprehensive profiles on these market players and assesses their current standing in the sterility testing market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.


Research Methodology


Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report consists of news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.


Analysis Period



  • Base Year - 2016

  • Projection Period - From 2017 to 2023

  • Market Denomination - USD Million

  • Conversion Rate - Considered as per the respective financial years


For the scope of research, the report offers a comprehensive analysis of the global sterility testing market.


Product Type



  • Instruments

  • Consumables

  • Services

    • Sterilization Validations

    • Cleaning and Disinfection

    • Stability Testing

    • Sterility Assurance Tests




Test Type



  • Product Flush Sterility Testing

  • Membrane Filtration Sterility Testing

  • Direct Transfer Sterility Testing

  • Others


End-user



  • Academic & Research Laboratories

  • Hospitals & Clinics

  • Pharmaceutical Companies

  • Others


By Region



  • Americas; The U.S. and Canada

  • Europe; Italy, France, the U.K., and Rest of Europe

  • Asia Pacific (APAC); China, India, and Rest of Asia Pacific

  • The Middle East & Africa; The Middle East and Africa


Intended Audience



  • Pharmaceutical Companies

  • Medical Research Laboratories

  • Biotechnological Institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

Global Sterility Testing Market: Report Summary


The global sterility testing market is predicted to touch USD 1,245.2 million by 2023 from USD 575 million in 2016, expanding at an astounding CAGR of 11.7% during the assessment period (2017-2023). The rise in demands for sterile drugs can open up avenues for suppliers and manufacturers of sterility testing market. Developing countries, such as China and India, owing to advancements in biotechnology and pharmaceuticals, are emerging as prospective markets and have turned out to be the favorite destination of investment of various market players who are now expanding their operations in these regions.


The sterility testing market is segmented on the basis of product type, test type, and end-user. By product type, the global market for sterility testing is segmented into instruments, consumables, and services. The service segment is sub-segmented into sterility assurance tests, sterilization validations, cleaning and disinfection, stability testing, and others. Mostly, sterility assurance tests are performed to determine the sterility-assurance level (SAL) of perishable pharmaceutical products, such as injectable to ensure the sterility of the drugs. Owing to these features, the sterility assurance tests segment held the largest market in 2016 with a market valuation of USD 67.1 million. Current predictions estimate its valuation at USD 151.6 million by the end of the forecast period.


Segmentation based on test type includes membrane filtration sterility testing, direct transfer sterility testing, product flush sterility testing, and others. The membrane filtration sterility test is a regulatory method for filterable pharmaceutical samples containing preservatives, bacteriostatic compounds, inhibiting the microbial growth of potential contaminants. This method helps in retaining microorganisms via 0.45-micron pore size filter, and suitable solutions are used to rinse all the inhibiting compounds. The technique is followed by the selection of an appropriate media to support the growth of anaerobic and aerobic microorganisms on the membrane filters. The final results come after an incubation period of 14 days. Furthermore, its advantages, such as applicability to large volume samples and ability to remove inhibitory substances from the sample, boost the growth of this segment. Currently, the membrane filtration sterility testing segment generates the largest market share and is expected to reach USD 348.6 million by 2023 with a stellar CAGR of 12.1% during the forecast period.


End-users comprise pharmaceutical companies, hospital & clinics, academic & research laboratories, and others. Treatment of chronic diseases, such as cancer, cardiovascular diseases, and others have spurred the demands for sterile injectables, which in turn ensured pharmaceutical companies’ domination of the global market.  A staggering growth has been predicted for this segment where it can reach USD 428.0 million, at a CAGR of 12.1% by the end of the foreccast period.


Regional Market Summary


The global sterility testing market, by regions, is segmented into the Americas, Europe, Asia Pacific (APAC) and the Middle East and Africa (MEA).


The Americas accounted for the most significant market share of about 42.1% in the global sterility testing market due to the presence of top-tier manufacturers, surging technological advancement in the pharmaceutical and biotechnology industries, and others.


Europe accounted for the second largest market share. The market in the region is experiencing a rapid increase in healthcare expenditures, and this can act as a market booster for sterility testing market.


The APAC market is expected to register the fastest CAGR of 12.4% during the forecast period. The region has a lot of developing economies with markets offering various opportunities making it a potential global influencer.  


The MEA has a few deterrents, such as the presence of low-income countries and stringent government regulations, which impeded the growth in the past. The MEA market accounted for the least market share in 2016.


Competitive Analysis


The key players of the global sterility testing market include Merck KGaA, Charles River Laboratories Inc., BioMérieux SA, Thermo Fisher Scientific Inc., BD, SGS SA, Baxter BioPharma Solutions, and others. Between 2014 and 2017, the primary market players were trying to sustain by adopting various growth strategies, such as expansion and mergers & acquisitions. For instance, BioMérieux SA acquired the U.S. company BioFire in 2014. Recently, consolidations are being witnessed in the market with the latest being the acquisition of MPI Research by Charles River Laboratories Inc. in 2018. Due to the substantial investments made by the key market players in expanding across borders, the global sterility testing market is experiencing an extensive growth.

License
Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency
TABLE OF CONTENTS

2.1 Introduction 15

2.2 Assumptions & Limitations 15

3.1 Research Process 18

3.2 Primary Research 18

3.3 Secondary Research 18

3.4 Market Size Estimation 19

4.1 Introduction 21

4.2 Drivers 22

4.2.1 Increasing demand for sterile drugs for the treatment of medical conditions such as cancer,

cardiovascular diseases, and others 22

4.2.2 Growing pharmaceutical and biotechnology sector provides suitable backgrounds for the market growth 22

4.2.3 Increasing government funding in the medical sector 22

4.2.4 Rising investments in life sciences 22

4.2.5 Drivers Impact Analysis 23

4.3 Restraints 23

4.3.1 High cost of sterility tests 23

4.3.2 Prolonged storage of perishable pharmaceutical products and need of trained professionals 23

4.3.3 Restraints Impact Analysis 24

4.4 Opportunity 24

4.4.1 Untapped markets of the Asia Pacific region 24

4.5 Mega Trends 24

4.5.1 Increasing adoption of rapid sterility testing 24

4.6 Macroeconomic Indicator 24

5.1 Value Chain Analysis 27

5.1.1 R&D & Designing 27

5.1.2 Manufacturing 27

5.1.3 Distribution & Sales 27

5.1.4 Post-Sales Review 28

5.2 Porter’s Five Forces Model 28

5.2.1 Bargaining Power of Suppliers 29

5.2.2 Bargaining Power of Buyers 29

5.2.3 Threat of New Entrants 29

5.2.4 Threat of Substitutes 29

5.2.5 Intensity of Rivalry 29

5.3 Investment Opportunities 30

5.4 Pricing Analysis 30

6.1 Introduction 32

6.2 Instruments 33

6.3 Consumables 33

6.4 Services 33

7.1 Introduction 35

7.2 Membrane Filtration Sterility Testing 36

7.3 Direct Transfer Sterility Testing 36

7.4 Product Flush Sterility Testing 36

8.1 Introduction 38

8.2 Pharmaceutical Companies 39

8.3 Hospital & Clinics 39

8.4 Academic & Research Laboratories 39

9.1 Introduction 41

9.2 Americas 42

9.2.1 North America 44

9.2.2 South America 49

9.3 Europe 51

9.3.1 Western Europe 53

9.3.2 Eastern Europe 64

9.4 Asia Pacific 66

9.4.1 China 68

9.4.2 India 70

9.4.3 Japan 71

9.4.4 Australia 73

9.4.5 Rest of Asia Pacific 74

9.5 Middle East & Africa 76

9.6 Middle East 78

9.6.1 Africa 79

10.1 Competitive Landscape 82

10.2 Competitive Landscape 83

10.2.1 Introduction 83

11.1 Merck KGaA 85

11.1.1 Company Overview 85

11.1.2 Products Offering 86

11.1.3 Key Developments 86

11.1.4 SWOT Analysis 86

11.1.5 Key Strategy 86

11.2 Pacific BioLabs Inc. 87

11.2.1 Company Overview 87

11.2.2 Products Offering 87

11.2.3 Key Developments 87

11.2.4 SWOT Analysis 87

11.3 Belimed Deutschland GmbH 88

11.3.1 Company Overview 88

11.3.2 Products Offering 89

11.3.3 Key Developments 89

11.3.4 SWOT Analysis 89

11.3.5 Key Strategy 89

11.4 Boston Scientific Corporation 90

11.4.1 Company Overview 90

11.4.2 Products Offering 91

11.4.3 Key Developments 91

11.4.4 SWOT Analysis 91

11.4.5 Key Strategy 91

11.5 Charles River Laboratories Inc. 92

11.5.1 Company Overview 92

11.5.2 Products Offering 93

11.5.3 Key Developments 93

11.5.4 SWOT Analysis 93

11.5.5 Key Strategy 93

11.6 Sartorius AG 94

11.6.1 Company Overview 94

11.6.2 Products Offering 95

11.6.3 Key Developments 95

11.6.4 SWOT Analysis 95

11.6.5 Key Strategy 95

11.7 BioMérieux SA 96

11.7.1 Company Overview 96

11.7.2 Products Offering 97

11.7.3 Key Developments 97

11.7.4 SWOT Analysis 97

11.7.5 Key Strategy 97

11.8 Baxter BioPharma Solutions 98

11.8.1 Company Overview 98

11.8.2 Products Offering 99

11.8.3 Key Developments 99

11.8.4 SWOT Analysis 99

11.8.5 Key Strategy 99

11.9 Astell Scientific 100

11.9.1 Company Overview 100

11.9.2 Products Offering 100

11.9.3 SWOT Analysis 100

 

11.10 SGS SA 101

11.10.1 Company Overview 101

11.10.2 Products Offering 102

11.10.3 Key Developments 102

11.10.4 SWOT Analysis 102

11.10.5 Key Strategy 102

11.11 Thermo Fisher Scientific Inc. 103

11.11.1 Company Overview 103

11.11.2 Products Offering 104

11.11.3 Key Developments 104

11.11.4 SWOT Analysis 104

11.11.5 Key Strategy 104

11.12 Becton, Dickinson and Company 105

11.12.1 Company Overview 105

11.12.2 Products Offering 105

11.12.3 Key Developments 106

11.12.4 SWOT Analysis 106

11.12.5 Key Strategy 106

11.13 WuXi AppTec 107

11.13.1 Company Overview 107

11.13.2 Products Offering 107

11.13.3 Key Developments 107

11.13.4 SWOT Analysis 107

11.14 Bioquell UK Ltd 108

11.14.1 Company Overview 108

11.14.2 Products Offering 108

11.14.3 SWOT Analysis 108

11.15 Azbil Telstar S.L. 109

11.15.1 Company Overview 109

11.15.2 Products Offering 109

11.15.3 SWOT Analysis 109

12 MRFR Conclusion 110

12.1 Key Findings 111

12.1.1 From CEO’s View Point 111

12.2 Key Companies to Watch 111

13 Appendix 112

13.1 Discussion Blue Print 113

13.2 Recent Developments, 2013–2017 114

TABLE 1 GLOBAL STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 32

TABLE 2 GLOBAL STERILITY TESTING MARKET FOR INSTRUMENTS 2014-2023 (USD MILLION) 33

TABLE 3 GLOBAL STERILITY TESTING MARKET FOR CONSUMABLES 2014-2023 (USD MILLION) 33

TABLE 4 GLOBAL STERILITY TESTING MARKET FOR SERVICES 2014-2023 (USD MILLION) 33

TABLE 5 GLOBAL STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 35

TABLE 6 GLOBAL STERILITY TESTING MARKET FOR MEMBRANE FILTRATION STERILITY TESTING 2014-2023 (USD MILLION) 36

TABLE 7 GLOBAL STERILITY TESTING MARKET FOR DIRECT TRANSFER STERILITY TESTING 2014-2023 (USD MILLION) 36

TABLE 8 GLOBAL STERILITY TESTING MARKET FOR PRODUCT FLUSH STERILITY TESTING 2014-2023 (USD MILLION) 36

TABLE 9 GLOBAL STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 38

TABLE 10 GLOBAL STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES 2014-2023 (USD MILLION) 39

TABLE 11 GLOBAL STERILITY TESTING MARKET FOR HOSPITAL & CLINICS 2014-2023 (USD MILLION) 39

TABLE 12 GLOBAL STERILITY TESTING MARKET FOR ACADEMIC & RESEARCH LABORATORIES 2014-2023 (USD MILLION) 39

TABLE 13 GLOBAL STERILITY TESTING MARKET BY REGION 2014-2023 (USD MILLION) 41

TABLE 14 AMERICAS STERILITY TESTING MARKET BY REGION 2014-2023 (USD MILLION) 42

TABLE 15 AMERICAS STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 43

TABLE 16 AMERICAS STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 43

TABLE 17 AMERICAS STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 44

TABLE 18 NORTH AMERICA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 44

TABLE 19 NORTH AMERICA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 45

TABLE 20 NORTH AMERICA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 45

TABLE 21 US STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 46

TABLE 22 US STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 46

TABLE 23 US STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 47

TABLE 24 CANADA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 47

TABLE 25 CANADA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 48

TABLE 26 CANADA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 48

TABLE 27 SOUTH AMERICA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 49

TABLE 28 SOUTH AMERICA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 49

TABLE 29 SOUTH AMERICA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 50

TABLE 30 EUROPE STERILITY TESTING MARKET BY REGION 2014-2023 (USD MILLION) 51

TABLE 31 EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 52

TABLE 32 EUROPE STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 52

TABLE 33 EUROPE STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 53

TABLE 34 WESTERN EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 53

TABLE 35 WESTERN EUROPE STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 54

TABLE 36 WESTERN EUROPE STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 54

TABLE 37 GERMANY STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 55

TABLE 38 GERMANY STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 55

TABLE 39 GERMANY STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 56

TABLE 40 FRANCE STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 56

TABLE 41 FRANCE STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 57

TABLE 42 FRANCE STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 57

TABLE 43 U.K STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 58

TABLE 44 U.K STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 58

TABLE 45 U.K STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 59

TABLE 46 ITALY STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 59

TABLE 47 ITALY STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 60

TABLE 48 ITALY STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 60

TABLE 49 SPAIN STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 61

TABLE 50 SPAIN STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 61

TABLE 51 SPAIN STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 62

TABLE 52 REST OF EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 62

TABLE 53 REST OF EUROPE STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 63

TABLE 54 REST OF EUROPE STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 63

TABLE 55 EASTERN EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 64

TABLE 56 EASTERN EUROPE STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 64

TABLE 57 EASTERN EUROPE STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 65

TABLE 58 ASIA PACIFIC STERILITY TESTING MARKET BY REGION 2014-2023 (USD MILLION) 66

TABLE 59 ASIA PACIFIC STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 67

TABLE 60 ASIA PACIFIC STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 67

TABLE 61 ASIA PACIFIC STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 68

TABLE 62 CHINA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 68

TABLE 63 CHINA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 69

TABLE 64 CHINA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 69

TABLE 65 INDIA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 70

TABLE 66 INDIA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 70

TABLE 67 INDIA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 71

TABLE 68 JAPAN STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 71

TABLE 69 JAPAN STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 72

TABLE 70 JAPAN STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 72

TABLE 71 ASUTRALIA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 73

TABLE 72 ASUTRALIA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 73

TABLE 73 ASUTRALIA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 74

TABLE 74 REST OF ASIA PACIFIC STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 74

TABLE 75 REST OF ASIA PACIFIC STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 75

TABLE 76 REST OF ASIA PACIFIC STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 75

TABLE 77 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY REGION 2014-2023 (USD MILLION) 76

TABLE 78 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 76

TABLE 79 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 77

TABLE 80 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 77

TABLE 81 MIDDLE EAST STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 78

TABLE 82 MIDDLE EAST STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 78

TABLE 83 MIDDLE EAST STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 79

TABLE 84 AFRICA STERILITY TESTING MARKET BY PRODUCT TYPE 2014-2023 (USD MILLION) 79

TABLE 85 AFRICA STERILITY TESTING MARKET BY TEST TYPE 2014-2023 (USD MILLION) 80

TABLE 86 AFRICA STERILITY TESTING MARKET BY END USER 2014-2023 (USD MILLION) 80

FIGURE 1 MARKET STRUCTURE 16

FIGURE 2 RESEARCH PROCESS 18

FIGURE 3 MARKET DYNAMICS ANALYSIS OF THE GLOBAL STERILITY TESTING MARKET 21

FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL STERILITY TESTING MARKET 23

FIGURE 5 RESTRAINTS IMPACT ANALYSIS: STERILITY TESTING MARKET 24

FIGURE 6 VALUE CHAIN: GLOBAL STERILITY TESTING MARKET 27

FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL STERILITY TESTING MARKET 28

FIGURE 8 GLOBAL STERILITY TESTING MARKET BY PRODUCT TYPE 2016 & 2023 (USD MILLION) 32

FIGURE 9 GLOBAL STERILITY TESTING MARKET BY TEST TYPE 2016 & 2023 (USD MILLION) 35

FIGURE 10 GLOBAL STERILITY TESTING MARKET BY END USER 2016 & 2023 (USD MILLION) 38

FIGURE 11 GLOBAL STERILITY TESTING MARKET BY REGION MARKET SHARE 2016 (%) 41

FIGURE 12 AMERICAS STERILITY TESTING MARKET SHARE BY REGION 2016 (%) 42

FIGURE 13 EUROPE STERILITY TESTING MARKET SHARE BY REGION 2016 (%) 51

FIGURE 14 ASIA PACIFIC STERILITY TESTING MARKET SHARE BY REGION 2016 (%) 66

FIGURE 15 MIDDLE EAST & AFRICA STERILITY TESTING MARKET SHARE BY REGION 2016 (%) 76

FIGURE 16 GLOBAL STERILITY TESTING MAJOR PLAYERS MARKET SHARE ANALYSIS, 2016 (%) 82

FIGURE 17 GLOBAL STERILITY TESTING MARKET, COMPETITIVE LANDSCAPE, 2016 (%) 83

Market Players have adopted the strategy of acquisitions, product launches, and partnerships for the development of the market


Merck KGaA is the market leader in the global sterility testing market with a market share of 18.7% in 2016. The company has a well-developed market, strong product portfolio, and effective distribution network around the globe. In the last three years, Merck KGaA has adopted the organic strategy of product launches and acquisitions to cement their position in the global sterility testing market. Moreover, the company has also increased investments in various R&D activities. This enabled them to launch innovative products in the market, thereby, expanding their market reach.


Charles River Laboratories Inc. assumed the second position in the global sterility testing market with a share of 12.4% in 2016. The company showed positive growth regarding revenue from 2015 to 2016 owing to strong sales in high potential emerging markets. Further, to sustain its place in the sterility testing market, the company follows strategic business strategies such as partnerships, collaborations, and acquisitions to expand their product portfolio and geographical reach. For instance, in July 2015, the company acquired Celsis International Ltd, which helped it in quality control testing of biopharmaceutical and consumer products industries.


BioMérieux SA was third in the global sterility testing market with a share of 9.3% in 2016. The company adopted the strategy of product launches to expand its market share and keep the sterility testing market updated. In addition, the company has a huge product portfolio and good brand identity.


Other prominent players in the market include Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), SGS SA, and Baxter BioPharma Solutions. Other players accounted for a share of 48.2% in the market in 2016. Majority of the companies have adopted the strategy of acquisitions and product launches for market development. For instance, in September 2016, the company announced the acquisition of the laboratory products and services segment of Alfa Aesar, a company based in the U.K., forUSD 392 million. This acquisition would help in expanding the company’s existing portfolio of chemicals, solvents, and reagents.